English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma

MPS-Authors
/persons/resource/persons147349

Wunderlich,  Frank Thomas
Wunderlich – Obesity and Cancer, Department Brüning, Max Planck Institute for Metabolism Research, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Peil, J., Vossen, C., Bock, F., Clahsen, T., Schiller, P., Heindl, L. M., et al. (2024). Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma. The Journal of Immunology, 212(3), 487-499. doi:10.4049/jimmunol.2300063.


Cite as: https://hdl.handle.net/21.11116/0000-000E-79BA-9
Abstract
There is no abstract available